Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Type
Public
HQ
Wayne, US
Founded
1995
Employees
115 (est)
Egalet was founded in 1995 and is headquartered in Wayne, US

Egalet Locations

Wayne, US

Egalet Metrics

Egalet Summary

Market capitalization

$190 M

Closing share price

$7.23
Egalet's latest market capitalization is $190 M.

Egalet Market Value History

Egalet Company Life

You may also be interested in